English
|
简体中文
Home
Products
·Human APIs
·Advanced intermediates
·Animal health
R&D and Manufacturing
·R&D
·Manufacturing
About us
·Introduction
·Vision
·Business model
·Quality policy
·Environmental
·Lean manufacturing
·Research
News
·Industry
·Company
Join us
·Career Opportunity
·Jobs
Contact
·Contact
Industry
Company
Home
>
News
>
Company
>
Hansynpharm's Posaconazole API was approved by CFDA
From:Jiangsu Hansyn Pharmaceutical
Date:2016-12-01
Click:279
Hansynpharm obtained Clinical Approval of Posaconazole API （No.2016L09420）from CFDA on Oct. 21st, 2016.
Back